Skip to content

Clinical trials

Bipolar Disorder trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: Brazil Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20081
20093
20103
20121
20145
20153
20161
20171
20192
20212
20222
20231
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15
Completed12
Recruiting4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo15
Hospital de Clinicas de Porto Alegre7
Federal University of Rio Grande do Sul3
Beny Lafer2
AstraZeneca1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Universidade Estadual de Londrina1
Universidade Estadual de Maringá1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder34
Attention Deficit Disorder with Hyperactivity3
Depressive Disorder3
Major Depressive Disorder3
Cognitive Dysfunction2
Inflammation2
Schizophrenia2
Insulin Resistance1
Mood Disorders1
Psychotic Disorders1

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.